X.—Mitosis and Cell Differentiation in the Blood

Author(s):  
L. F. La Cour

It was in 1878 that Ehrlich, with the aid of his triacid stain, described in terms of granulation of the cytoplasm six types of leucocytes. This marked the first real advance in our knowledge of the blood corpuscles. Present-day classification of cells in the blood-forming tissues gives six main groups with about thirty named types of cells. These fine subdivisions appear to represent different stages in different lines of development from one original type, chiefly by change in the shape of the resting nucleus. Divergence in opinion arises as to whether all these types of cell develop in the red bone marrow, or whether some arise elsewhere in the body.

1923 ◽  
Vol 38 (5) ◽  
pp. 529-541 ◽  
Author(s):  
H. E. Jordan ◽  
C. C. Speidel

1. Thyroid-accelerated metamorphosis in the larval frog is accompanied by changes in the hemopoietic centers and in the blood cell distribution in the various regions of the body. These changes are interpreted as results of the fundamental change in basal metabolic rate induced by the thyroid treatment. 2. There is initiation of the shift of hemopoietic locus from the kidney, the larval hemopoietic organ, to the spleen, the adult hemopoietic organ. The spleen, being chiefly an erythrocyte producer, becomes of greater importance with the transition from the lower metabolic rate to the higher, since greater erythropoiesis becomes necessary to supply the physical basis for the maintenance of the higher metabolic rate. 3. It is suggested that the appearance of red bone marrow in the later history of the frog is correlated with a still higher metabolic rate. Phylogenetically, in the vertebrate series, red bone marrow is also associated with higher metabolic rate. 4. The new metabolic rate initiated in tadpoles by thyroid administration sets up a demand for (a) erythrocytes, (b) granulocytes and lymphoid phagocytes for distribution to regions of regressive change, (c) lymphocytes, (1) as progenitors of erythrocytes, granulocytes and phagocytes, (2) for promoting growth of cells in regions of progressive change. 5. Upon the hemopoietic reserve, which in the last analysis is the lymphocyte (and its mesenchymal precursor), depends the extent to which metamorphosis will proceed. Inability on the part of the hemopoietic centers, chiefly the spleen, to keep pace with the demand for blood cells during metamorphosis results in metamorphic stasis, a condition of anemia which is usually followed by death. 6. The growth-promoting function of leucocytes, as demonstrated by Carrel, is probably to be ascribed to the lymphocyte component of leucocytes. 7. The granulocytes have probably also a glandular function, and may exert a lytic effect upon adjacent tissues in regions of regressive change.


1927 ◽  
Vol 46 (5) ◽  
pp. 689-698 ◽  
Author(s):  
A. Jeney

1. Respiratory exchange measurements may be used for gaining further evidence concerning the body changes during anemia, and are complementary to the hematological and histological data. 2. The heat production during anemia was slightly decreased. At the 3rd week it began to rise. 3. A protein-free liver extract has accelerated blood regeneration and at the same time increased the respiratory exchange of anemic animals. 4. A protein-free spleen extract has distinctly lowered the respiratory exchange of normal animals. The metabolism of anemic animals thus treated was practically the same as before bleeding and treatment. The recovery of the spleen extract-treated animals was not complete during the period of observation. This extract may have been somewhat toxic. In spite of this disturbing factor we are not inclined to accept the view of C. D. and E. W. Leake (15) and Thalhimer (16) that the spleen takes part in the stimulating effect upon blood regeneration when given in combination with red bone marrow by mouth.


2020 ◽  
Vol 98 (Supplement_4) ◽  
pp. 256-256
Author(s):  
Evgeniy Mikhaylov ◽  
Yulia Shaposhnikova ◽  
Boris Shabunin ◽  
Igor Tolkachev ◽  
Svetlana Vorotnikova ◽  
...  

Abstract The experiment was conducted on newborn hypotrophic piglets obtained from sows of the 3rd–4th farrow on the farm in the Voronezh region. Bone marrow for histochemical and ultrastructural studies was selected from hypotrophic piglets with a body weight less than 800 g (n = 13). The material for electron microscopy was carried out in 2.5% glutaraldehyde in 0.114 M colloid buffer in the cold with postfixation in 1% solution of osmium tetroxide in the same buffer. The material was enclosed in epon-812. Semithin sections were stained with azur-2 in combination with the main fuchsin and were examined under Leica light microscope. Ultrathin sections were prepared on Ultracut (Leica) ultramicrotome, contrasted with lead citrate and uranyl acetate and examined under EM-208 (Philips) electron microscope. In hypotrophic piglets, the cells forming in the red bone marrow are located as islands. Hypoplasia of cells of the hemopoetic series occurred, proerythroblasts and megacaryoblasts were observed in insignificant quantity. Megakaryocytes were closely adjacent to sinusoidal capillaries, and a part of their cytoplasm penetrated into the lumen of blood vessels. Separating fragments of cytoplasm in the form of platelets were transferred to the blood flow. Light mitochondria with a few small electron-dense cristae were observed in the ultrastructure of cells of the bone marrow. The emergence of immature forms, which indicated bone marrow function disorder or its barrier damage, was also observed in the blood flow. At the same time there occurred a decrease in the number of differentiated cells and their differentiation disorder, which could lead to immunodeficiency state. Differentiation of cells in the bone marrow of hypotrophic piglets is impaired, and that is why the body is not provided with a sufficient number of blood cells. Blast cells, which appear in the blood flow, cannot fully perform their functions, resulting in immunodeficiency and anemia.


2020 ◽  
Vol 2 (1) ◽  
pp. 54-69
Author(s):  
Aleksandr V. Vodovatov ◽  
Larisa A. Chipiga ◽  
Anna E. Petrova ◽  
Andrey A. Stanzhevsky

Prostate cancer is the most common men urogenital tumor. For most patients with the disseminated neoplastic process in the prostate after the hormonal therapy, the disease gradually progresses in the form of castration-resistant prostate cancer (mCRPC). The use of 223Ra agents is aimed at the treatment of the bone lesions as part of palliative therapy. The physical properties of 223Ra significantly complicate the require direct radiometry for patients with alpha emitters. Hence, the distribution of 223Ra in the body should be evaluated based on the dedicated biodistribution models. The aim of this study was to review and analyze the existing approaches to the evaluation of the biodistribution of 223Ra and its pharmaceutical forms (223Ra-dichloride) for the further assessment of absorbed doses in radiosensitive organs and tissues. The study includes the mathematical models for the estimation of the absorbed doses in various organs and tissues of the body. A review of three different 223Ra biodistribution models is presented: two ICRP models for occupational exposure and a model based on the results of an experimental assessment of 223Ra distribution in patients with mCRPC. It was indicated that the latter model is in good agreement with the results of direct radiometry of patients. A significant drawback of all models is the simulation of the red bone marrow and bone surface as single chambers. During the radionuclide therapy, 223Ra will specifically accumulate in bone metastases, instead of being evenly distributed in the skeleton. Hence, the use of any of the reviewed models will lead both to a significant overestimation of the absorbed dose in a healthy part of the bone surface and red bone marrow, and to an underestimation of the absorbed dose in bone metastases. Currently, this problem has not been solved. That requires the development of new improved models that consider the accumulation of 223Ra in the healthy part of the skeleton and in skeletal metastases.


Bone Reports ◽  
2021 ◽  
Vol 14 ◽  
pp. 100989
Author(s):  
Viktorija Avilkina ◽  
Damien Leterme ◽  
Guillaume Falgayrac ◽  
Pierre Marchandise ◽  
Flore Miellot ◽  
...  

2006 ◽  
Vol 45 (03) ◽  
pp. 134-138 ◽  
Author(s):  
T. Kull ◽  
N. M. Blumstein ◽  
D. Bunjes ◽  
B. Neumaier ◽  
A. K. Buck ◽  
...  

SummaryAim: For the therapeutic application of radiopharmaceuticals the activity is determined on an individual basis. Here we investigated the accuracy for a simplified assessment of the residence times for a 188Re-labelled anti-CD66 monoclonal antibody. Patients, methods: For 49 patients with high risk leukaemia (24 men, 25 women, age: 44 ± 12 years) the residence times were determined for the injected 188Re-labelled anti-CD66 antibodies (1.3 ± 0.4 GBq, 5–7 GBq/mg protein, >95% 188Re bound to the antibody) based on 5 measurements (1.5, 3, 20, 26, and 44 h p.i.) using planar conjugate view gamma camera images (complete method). In a simplified method the residence times were calculated based on a single measurement 3 h p.i. Results: The residence times for kidneys, liver, red bone marrow, spleen and remainder of body for the complete method were 0.4 ± 0.2 h, 1.9 ± 0.8 h, 7.8 ± 2.1 h, 0.6 ± 0.3 h and 8.6 ± 2.1 h, respectively. For all organs a linear correlation exists between the residence times of the complete method and the simplified method with the slopes (correlation coefficients R > 0.89) of 0.89, 0.99, 1.23, 1.13 and 1.09 for kidneys, liver, red bone marrow, spleen and remainder of body, respectively. Conclusion: The proposed approach allows reliable prediction of biokinetics of 188Re-labelled anti-CD66 monoclonal antibody biodistribution with a single study. Efficient pretherapeutic estimation of organ absorbed dose may be possible, provided that a more stable anti-CD66 antibody preparation is available.


2011 ◽  
Vol 20 (1) ◽  
pp. 161-173
Author(s):  
A.P. Kassatkina

Resuming published and own data, a revision of classification of Chaetognatha is presented. The family Sagittidae Claus & Grobben, 1905 is given a rank of subclass, Sagittiones, characterised, in particular, by the presence of two pairs of sac-like gelatinous structures or two pairs of fins. Besides the order Aphragmophora Tokioka, 1965, it contains the new order Biphragmosagittiformes ord. nov., which is a unique group of Chaetognatha with an unusual combination of morphological characters: the transverse muscles present in both the trunk and the tail sections of the body; the seminal vesicles simple, without internal complex compartments; the presence of two pairs of lateral fins. The only family assigned to the new order, Biphragmosagittidae fam. nov., contains two genera. Diagnoses of the two new genera, Biphragmosagitta gen. nov. (type species B. tarasovi sp. nov. and B. angusticephala sp. nov.) and Biphragmofastigata gen. nov. (type species B. fastigata sp. nov.), detailed descriptions and pictures of the three new species are presented.


2021 ◽  
pp. 106611
Author(s):  
Maria Zankl ◽  
Jonathan Eakins ◽  
José-María Gómez Ros ◽  
Christelle Huet
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document